# Vizimpro

NDC: 63539-197
Generic name: dacomitinib
Labeler / Manufacturer: U.S. Pharmaceuticals
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20190201

FDA application: NDA211288

## Active ingredients

- DACOMITINIB: 15 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63539-197"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63539-197
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=90da33c1-5689-4b4d-a2b5-377e1057a843